Zydus receives USFDA approval for Verapamil Hydrochloride Extended-Release Tablets



Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg (USRLD: Calan SR Extended-Release Tablets, 120 mg, 180 mg and 240 mg).



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *